As of 17 Sept 2026, Max Healthcare Institute Ltd share price is ₹1,032.60. The stock opened at ₹1,032.60 and had closed at ₹1,027.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹903.50 and a high of ₹1,221.10. In terms of performance, Max Healthcare Institute Ltd share price has increased by 5.42% over the past six months and has decreased by 12.00% over the last year.
MAXHEALTH Stock Price Chart
Max Healthcare Institute Ltd Overview
About MAXHEALTH
Max Healthcare Institute engaged in provision of healthcare services through primary care clinics, multi-speciality hospitals/medical centres and super-speciality hospital facilities
Max Healthcare Institute Ltd Historical Performance
MAXHEALTH Futures & Options
Max Healthcare Institute Ltd Fundamentals
Max Healthcare Institute Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 3,176.40 | 3,030.14 | 2,607.42 | 2,048.83 | 1,903.48 |
| EBITDA | 1,106.89 | 1,126.30 | 1,033.26 | 728.26 | 571.38 |
| Net Profit | 716.61 | 701.07 | 687.26 | 694.31 | 331.52 |
| EPS | 7.37 | 7.21 | 7.07 | 7.16 | 3.43 |
Max Healthcare Institute Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,020.48 |
| Resistance 1 (R1) | 1,040.18 |
| Pivot Point | 1,033.62 |
Max Healthcare Institute Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 03-Jul-2026 | 21-May-2026 | 03-Jul-2026 | Final | ₹2.00 |
| 04-Jul-2025 | 20-May-2025 | 04-Jul-2025 | Final | ₹1.50 |
| 23-Aug-2024 | 22-May-2024 | 23-Aug-2024 | Final | ₹1.50 |
| 08-Sep-2023 | 16-May-2023 | 08-Sep-2023 | Final | ₹1.00 |
MAXHEALTH Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Abhay Soi | Chairman & Managing Director |
| Anil Bhatnagar | Non Executive Independent Director |
| Narayan Seshadri | Non Executive Independent Director |
Max Healthcare Institute Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
| Narayana Hrudayalaya LtdNH | ₹1,851.60-2.29% | ₹35,563.89 | 45.64 | 17.76% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Max Healthcare Institute Ltd today is ₹1,032.60 on NSE and ₹1,032.60 on BSE.
- The 52-week high of Max Healthcare Institute Ltd is ₹1,221.10, while the 52-week low is ₹903.50.
- The current market capitalisation of Max Healthcare Institute Ltd is approximately ₹1,00,504 crore.
- The P/E (Price-to-Earnings) ratio of Max Healthcare Institute Ltd is 72.27. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Max Healthcare Institute Ltd is 10.20. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Max Healthcare Institute Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for MAXHEALTH on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Max Healthcare Institute Ltd has delivered a return of approximately 80.08%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Max Healthcare Institute Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 23.71% promoters, 23.09% FIIs, 29.96% DIIs, and 3.22% public shareholders.

